Chronic kidney disease develops among 30% to 40% of people with type 1 or type 2 diabetes during their lifetime. Author Ian H. de Boer, MD, MS, of the University of Washington Division of Nephrology, discusses the evaluation and treatment of chronic kidney disease in patients with type 1 and type 2 diabetes with JAMA Senior Editor Karen Lasser, MD, MPH.
Editor-in-Chief Job Description About the Journal Global Perspectives on Nutrition will be an open access journal that provides a platform for high-quality re
Indian-Americans who remember life before the polio vaccine are worried about what RFK Jr. could do in the U.S.
The tech company has made Copilot part of its 365 subscription service in several markets and raised prices.
Background Burnout among healthcare providers affects their well-being and quality of care. Despite its importance, limited data exist on burnout among primary healthcare providers in…
Schafer Boeder, MD describes the potential role and safety of adjunctive therapy, including SGLT2 inhibitors and GLP-1 agonists, for patients with T1D.
We finally have a real definition of the elusive “AGI.”
This scoping review of randomised controlled trials on artificial intelligence (AI) in clinical practice reveals an expanding interest in AI across clinical specialties and locations.…
After starting off slow, China’s EV industry has reorganized itself in record time, going from a global laggard to a…
Hannah Witton, a prominent sex educator on YouTube, recently stepped away from her 12-year career on the platform to to help other content creators.
Gen Z cashiers are infuriating their bosses when they take cash from customers.
